Pure Global
NCT06266559

Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease

Chang Gung Memorial Hospital·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Non-Alcoholic Fatty Liver Disease
Drug/Device/Intervention
Chang Geng Healthy Drink
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Chang Gung Memorial Hospital
Timeline & enrollment
Phase
N/A
Start date
Feb 15, 2024
End date
Dec 31, 2025
Enrollment
60 participants
Primary outcome

Fatigue Visual Analogue Scale - Current fatigue level,Fatigue Visual Analogue Scale - Other daily specific task fatigue level,Laboratory Data (Linver Function Index),Liver stiffness measurement (kPa),Controlled attenuation parameter (dB/m)

Summary

For non-alcoholic fatty liver disease, there is currently no effective treatment options.
 Traditional Chinese medicine (TCM) has a long history of treating liver diseases. However,
 TCM treatment methods are diverse, and there is currently a lack of high-quality clinical
 research to confirm the efficacy of Chinese herbal medicine. Thereafter, Chang-Gung Healthy
 Drink which is a TCM based healthy drink may be used to alleviate the clinical adverse event
 of non-alcoholic fatty liver disease patients.

ICD-10 classifications
Alcoholic fatty liverAlcoholic liver disease, unspecifiedAlcoholic liver diseaseLiver disease, unspecifiedAlcoholic cirrhosis of liver
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06266559
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06266559 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Not yet recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.